Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04496739 · ClinicalTrials.gov registry record · NA

Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE)

A NA study of Lobular Breast Carcinoma in Situ and Atypical Hyperplasia of the Breast, sponsored by SWOG Cancer Research Network.

Active
Registry status
NA
Development phase
412
Enrollment target
20
Study locations

NCT04496739 is a NA study of Lobular Breast Carcinoma in Situ and Atypical Hyperplasia of the Breast that is active but no longer recruiting, run by SWOG Cancer Research Network. The registered enrollment target is 412 participants, above the 79-participant average among 5 other Lobular Breast Carcinoma in Situ trials with a reported enrollment target (422% higher). The trial reports 20 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04496739, a NA study of Lobular Breast Carcinoma in Situ and Atypical Hyperplasia of the Breast, is active but no longer recruiting, sponsored by SWOG Cancer Research Network.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
412 participants
Enrollment target
20
Study locations

Study Summary

This trial studies the implementation of web-based decision support tools for patients with atypical hyperplasia or lobular carcinoma in situ and healthcare providers. Decision support tools are designed to improve informed choice about breast cancer chemoprevention. Recognizing barriers and facilitators that can influence the adoption of decision support tools at recruitment centers may help researchers learn how to best implement them into clinical practice.

Conditions Studied

Lobular Breast Carcinoma in Situ Atypical Hyperplasia of the Breast Pleomorphic Lobular Breast Carcinoma In Situ

Interventions

  • OTHER Questionnaire Administration
  • OTHER Interview
  • OTHER Decision Aid
  • BEHAVIORAL Cancer Educational Materials

Study Locations (20)

California

  • Kaiser Permanente-Deer Valley Medical Center - Antioch
  • UC Irvine Health Cancer Center-Newport - Costa Mesa
  • City of Hope Comprehensive Cancer Center - Duarte
  • Kaiser Permanente-Oakland - Oakland
  • UC Irvine Health/Chao Family Comprehensive Cancer Center - Orange
  • Kaiser Permanente Downtown Commons - Sacramento
  • Kaiser Permanente-South Sacramento - Sacramento
  • Kaiser San Rafael-Gallinas - San Rafael
  • Kaiser Permanente Medical Center - Santa Clara - Santa Clara
  • City of Hope South Pasadena - South Pasadena
  • Kaiser Permanente-South San Francisco - South San Francisco
  • Kaiser Permanente-Vallejo - Vallejo
  • Kaiser Permanente-Walnut Creek - Walnut Creek

Florida

  • Mount Sinai Comprehensive Cancer Center at Aventura - Aventura
  • Miami Cancer Institute - Miami
  • Mount Sinai Medical Center - Miami Beach
  • Miami Cancer Institute at Plantation - Plantation

Georgia

  • Grady Health System - Atlanta
  • Emory University Hospital Midtown - Atlanta
  • Emory University Hospital/Winship Cancer Institute - Atlanta

Trial Details

FieldValue
Enrollment Target 412 participants
Start Date 2020-10-23
Est. Completion 2028-06-01
Phase NA

Sponsor

SWOG Cancer Research Network

270 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04496739

The ClinicalTrials.gov registry entry for NCT04496739 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 412 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 79-participant average among 5 other Lobular Breast Carcinoma in Situ trials with a reported enrollment target (422% higher). The listed sponsor is SWOG Cancer Research Network, which has 270 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Lobular Breast Carcinoma in Situ appearing as the primary indexed condition, and to 4 interventions - of which Questionnaire Administration is the first listed.

NCT04496739 reports 20 study locations spanning 3 distinct geographic areas - top geographies include California, Florida, Georgia.

Frequently Asked Questions

What is clinical trial NCT04496739 about?

NCT04496739 is a clinical study titled "Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE)". This trial studies the implementation of web-based decision support tools for patients with atypical hyperplasia or lobular carcinoma in situ and healthcare providers. Decision support tools are designed to improve informed choice about breast cancer chemoprevention. Recognizing barriers and facilit...

What is the current status of trial NCT04496739?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 412 participants. The study started on 2020-10-23. Estimated completion is 2028-06-01.

What conditions does trial NCT04496739 study?

This clinical trial studies the following conditions: Lobular Breast Carcinoma in Situ, Atypical Hyperplasia of the Breast, Pleomorphic Lobular Breast Carcinoma In Situ.

What interventions are being tested in trial NCT04496739?

The interventions under investigation include: Questionnaire Administration (OTHER), Interview (OTHER), Decision Aid (OTHER), Cancer Educational Materials (BEHAVIORAL).

Who is sponsoring clinical trial NCT04496739?

This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04496739 being conducted?

This trial has 20 study locations across California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lobular Breast Carcinoma in Situ

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lobular Breast Carcinoma in Situ

All registered trials for this condition

Atypical Hyperplasia of the Breast

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.